Transdermal drug delivery system (TDDS) is the third drug delivery system after oral administration and injection. It has the advantages of good therapeutic effect and independent medication. It is estimated that by 2026, the global transdermal patch market is expected to reach US$10.67 billion. Previously, my country's transdermal drug delivery system was dominated by traditional patches. In the past two years, with the introduction of a series of national incentive policies, the development of new and high-performance pharmaceutical excipients, and the advancement of dermatology, research in the field of transdermal preparations in my country has With the rapid development of medical technology and applications, many pharmaceutical companies have increased investment in research and development and are vying to deploy in key areas.

However, at the same time, my country's transdermal preparation industry is also facing a series of challenges, such as insufficient technological innovation, insufficient industrial collaboration, and insufficient policy support. In order to promote the development of the field of transdermal preparations in my country, strengthen exchanges and cooperation within the industry, improve research and development levels, and promote technological innovation, the Pharmaceutical Fusion Circle will hold the "Transdermal Preparations Conference" at the same time as the CMC China Expo on August 15-16, 2024. ”, the conference aims to build an industry exchange platform with shared resources and value creation, promote in-depth exchanges and cooperation among experts, scholars, and pharmaceutical companies in the field of domestic transdermal preparations, expand the transdermal preparation industry market, and help my country’s transdermal preparations High-quality development in the field of preparations.